Authors: Carpene G, Negrini D, Henry BM, Montagnana L, Lippi G PMID: 35704707 DOI: 10.1515/dx-2022-0042 Abstract Objectives: Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disorder characterized by a sustained prothrombotic state. Since homocysteine is a potential biomarker of thrombotic diseases, the aim of this article is to provide an updated overview on the possible [...]

Authors: Perez JC, Moret-Chalmin C, Montagnier L DOI: 10.5281/zenodo.6641999 Abstract "Resubmitted preprint withdrawn after 132 000 reads on RESEARCHGATE" We highlight the presence of a Prion region in the different Spike proteins of the original SARS-CoV2 virus as well as of all its successive variants but also of all the “vaccines” built on this same [...]

Authors: Charnley M, Islam S, Bindra G, Ratcliffe J, Zhou J, Hulett M Abstract COVID-19 is primarily known as a respiratory disease caused by SARS-CoV-2. However, neurological symptoms such as memory loss, sensory confusion, severe headaches, and even stroke are reported in up to 30% of cases and can persist even after the infection is [...]

Authors: Nystrom S, Hammarstrom P PMID: 35579205 PMCID: PMC9136918 DOI: 10.1021/jacs.2c03925 Abstract SARS-CoV-2 infection is associated with a surprising number of morbidities. Uncanny similarities with amyloid-disease associated blood coagulation and fibrinolytic disturbances together with neurologic and cardiac problems led us to investigate the amyloidogenicity of the SARS-CoV-2 spike protein (S-protein). Amyloid fibril assays of peptide [...]

Authors: Mostafa-Hedeab G, Al-kuraishy HM, Al-Gareeb AA, Jeandet P, Saaad HM, El-Saber Batiha G PMID: 35486310 PMCID: PMC9051499 DOI: 10.1007/s10787-022-00993-1 Abstract The existing pandemic viral infection caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) leads to coronavirus disease 2019 (Covid-19). SARS-CoV-2 exploits angiotensin-converting enzyme 2 (ACE2) as an entry-point into affected cells and [...]

Authors: Brown JT, Saigal A, Karia N, Patel RK, Razvi Y, Steeden JA PMID: 35470679 PMCID: PMC9238618 DOI: 10.1161/JAHA.121.024207 Abstract Background Ongoing exercise intolerance of unclear cause following COVID-19 infection is well recognized but poorly understood. We investigated exercise capacity in patients previously hospitalized with COVID-19 with and without self-reported exercise [...]

Authors: Burakgazi AZ PMID: 35702058 PMCID: PMC9149535 doi: 10.1159/000524205 Abstract COVID-19 has caused several neurological complications by affecting the central and peripheral nervous systems (PNS). Studies on the PNS involvement in COVID-19 are limited. These complications are likely unreported, given the difficulty of obtaining further diagnostic information, such as expert neurologist evaluation, electrodiagnostic testing, and [...]

Authors: Seneff S, Nigh G, Kyriakopoulos AM, McCullough PA PMID: 35436552 PMCID: PMC9012513 DOI: 10.1016/j.fct.2022.113008 Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease has no precedent. The many alterations in the vaccine mRNA hide [...]

Authors: Schauer J, Buddhe S, Gulhane A, Sagiv E PMID: 35351530 PMCID: PMC8957353 DOI: 10.1016/j.jpeds.2022.03.032 Abstract We describe the evolution of cardiac magnetic resonance imaging findings in 16 patients, aged 12-17 years, with myopericarditis after the second dose of the Pfizer mRNA coronavirus disease 2019 vaccine. Although all patients showed rapid clinical improvement, many had [...]

Authors: Zhang Z, Ren JG, Guo JL, An L, Li S, Zhang ZC PMID: 35338068 PMCID: PMC8960464 DOI: 10.1136/bmjopen-2021-059067 Abstract Introduction: COVID-19 is a public health emergency of international concern, which is characterised by rapid and widespread transmission, high mortality and complications. Several studies have shown the benefits of tai chi and qigong for recovery [...]